FI924082A0 - Idiotypvaccination mot b-cellymfoma. - Google Patents

Idiotypvaccination mot b-cellymfoma.

Info

Publication number
FI924082A0
FI924082A0 FI924082A FI924082A FI924082A0 FI 924082 A0 FI924082 A0 FI 924082A0 FI 924082 A FI924082 A FI 924082A FI 924082 A FI924082 A FI 924082A FI 924082 A0 FI924082 A0 FI 924082A0
Authority
FI
Finland
Prior art keywords
dendritic cells
idiotype
pulsed
cells
idiotypvaccination
Prior art date
Application number
FI924082A
Other languages
English (en)
Other versions
FI924082A (fi
FI105452B (fi
Inventor
Heribert Bohlen
Jacques Urbain
Camp Benjamin Van
Kristiaan Thielemans
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23960532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI924082(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI924082A publication Critical patent/FI924082A/fi
Publication of FI924082A0 publication Critical patent/FI924082A0/fi
Application granted granted Critical
Publication of FI105452B publication Critical patent/FI105452B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI924082A 1990-03-14 1992-09-11 Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan FI105452B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49351190 1990-03-14
US07/493,511 US20030072751A1 (en) 1990-03-14 1990-03-14 Idiotypic vaccination against b cell lymphoma
US9101683 1991-03-13
PCT/US1991/001683 WO1991013632A1 (en) 1990-03-14 1991-03-13 Idiotypic vaccination against b cell lymphoma

Publications (3)

Publication Number Publication Date
FI924082A FI924082A (fi) 1992-09-11
FI924082A0 true FI924082A0 (fi) 1992-09-11
FI105452B FI105452B (fi) 2000-08-31

Family

ID=23960532

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924082A FI105452B (fi) 1990-03-14 1992-09-11 Idiotyyppirokotuksen valmistus B-solulymfoomaa vastaan

Country Status (12)

Country Link
US (1) US20030072751A1 (fi)
EP (1) EP0521897B1 (fi)
JP (1) JP2735947B2 (fi)
AT (1) ATE124265T1 (fi)
AU (1) AU645552B2 (fi)
CA (1) CA2078235C (fi)
DE (1) DE69110877T2 (fi)
DK (1) DK0521897T3 (fi)
ES (1) ES2074268T3 (fi)
FI (1) FI105452B (fi)
NO (1) NO308509B1 (fi)
WO (1) WO1991013632A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004807A (en) * 1992-03-30 1999-12-21 Schering Corporation In vitro generation of human dendritic cells
CA2133409C (en) * 1992-04-01 2011-05-24 Ralph M. Steinman Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
AU687733B2 (en) * 1992-04-01 1998-03-05 Rockefeller University, The Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens
EP1421947A1 (en) * 1992-07-22 2004-05-26 The Trustees Of Princeton University p53 vaccine
DE69331703D1 (de) * 1992-08-21 2002-04-18 Us Gov Health & Human Serv B-lymphomazellinie und antigen
US5651993A (en) 1992-11-18 1997-07-29 Yale University Specific immune system modulation
CA2158281A1 (en) * 1993-03-15 1994-09-29 Jay A. Berzofsky Peptide coated dendritic cells as immunogens
WO1995034638A1 (en) * 1994-06-14 1995-12-21 The Board Of Trustees Of Leland Stanford Junior University Methods for in vivo t cell activation by antigen-pulsed dendritic cells
US6300090B1 (en) 1994-07-29 2001-10-09 The Rockefeller University Methods of use of viral vectors to deliver antigen to dendritic cells
US6340981B1 (en) 1997-06-30 2002-01-22 Sun Microsystems, Inc. Method and apparatus for stroke substitution
US6010905A (en) * 1995-01-27 2000-01-04 The United States Of America As Represented By The Department Of Health & Human Services Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells
US5788963A (en) * 1995-07-31 1998-08-04 Pacific Northwest Cancer Foundation Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
WO1997022349A1 (en) * 1995-12-20 1997-06-26 The Board Of Trustees Of The Leland Stanford Junior University Methods for in vivo t cell activation by antigen-pulsed dendritic cells
US6080409A (en) 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
US7659119B2 (en) 1996-02-12 2010-02-09 Argos Therapeutics, Inc. Method and compositions for obtaining mature dendritic cells
US5776746A (en) 1996-05-01 1998-07-07 Genitope Corporation Gene amplification methods
ATE428769T1 (de) 1997-10-27 2009-05-15 Univ Rockefeller Methode und zusammensetzung zur herstellung von reifen dendritischen zellen
CA2321093A1 (en) 1998-02-20 1999-08-26 The Rockefeller University Apoptotic cell-mediated antigen presentation to dendritic cells
US8313945B2 (en) 1999-04-20 2012-11-20 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells
CA2368855C (en) 1999-04-20 2012-05-29 Richard Leslie Edelson Differentiation of monocytes into functional dendritic cells
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
AT409086B (de) * 1999-11-16 2002-05-27 Igeneon Krebs Immuntherapie Neue verwendung von antikörpern als impfstoffe
US8524495B2 (en) 2007-05-16 2013-09-03 Yale University Methods for inducing the differentiation of blood monocytes into functional dendritic cells

Also Published As

Publication number Publication date
JPH05507905A (ja) 1993-11-11
CA2078235A1 (en) 1991-09-15
EP0521897B1 (en) 1995-06-28
AU7488691A (en) 1991-10-10
ES2074268T3 (es) 1995-09-01
FI924082A (fi) 1992-09-11
DE69110877D1 (de) 1995-08-03
EP0521897A1 (en) 1993-01-13
CA2078235C (en) 2004-01-20
JP2735947B2 (ja) 1998-04-02
US20030072751A1 (en) 2003-04-17
NO923542D0 (no) 1992-09-11
AU645552B2 (en) 1994-01-20
DE69110877T2 (de) 1995-11-16
ATE124265T1 (de) 1995-07-15
NO923542L (no) 1992-09-11
NO308509B1 (no) 2000-09-25
WO1991013632A1 (en) 1991-09-19
FI105452B (fi) 2000-08-31
DK0521897T3 (da) 1995-11-13

Similar Documents

Publication Publication Date Title
FI924082A0 (fi) Idiotypvaccination mot b-cellymfoma.
IT1248760B (it) Dispositivo di iniezione del combustibile per motori e endotermici
DK0504177T3 (da) IL-11, et pattedyrcytokin
DK0669836T3 (da) Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom
DE3854174D1 (de) Kraftstoffeinspritzventil.
ATE147633T1 (de) Immunhilfsmittel aus liposome enthaltend lymphokin il -2
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
MY135673A (en) Monoclonal antibodies for inducing tolerance
BR8900510A (pt) Injetor de combustivel
DE68912995D1 (de) Kraftstoffeinspritzventil.
KR890700659A (ko) 항원-특이적 t세포주의 생성방법 및 이의 치료적 용도
IT1167325B (it) Polverizzatore per iniettori del combustibile di motori diesel
IT8050422A0 (it) Dispositivo per la riduzione delle vibrazioni di motori in particolare di motori endotermici ad iniezione
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
DE69322960D1 (de) Empfängnisverhütender impfstoff
Thonard Host defense mechanisms in the oral mucosa
NO872633L (no) Monoklonalt antistoff mot humant plasminogen, samt fremstilling derav.
IT1229943B (it) Procedimento e dispositivo di misura dell'anticipo di inizio mandata dell'iniezione, particolarmente in motori diesel
IT1181513B (it) Sistema di fissaggio dell'imbottitura sui fianchi di una poltrona
ITMI913291A1 (it) Dispositivo e procedimento di iniezione del combustibile
SE8702038D0 (sv) Sett och anordning for att alstra seismiska pulser
ES556316A0 (es) Dispositivo verificador de inyectores de combustible
IT8304205V0 (it) Iniettore di piccole dimensioni per motori diesel.

Legal Events

Date Code Title Description
MA Patent expired